Press Releases April 6, 2026 08:00 PM

Sysco to Announce Third Quarter Fiscal Year 2026 Financial Results on April 28

Sysco Schedules Announcement of Q3 Fiscal 2026 Financial Results on April 28

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
SYY

Sysco Corporation, the global leader in food distribution for the food-away-from-home market, will announce its third quarter fiscal year 2026 financial results on April 28, 2026. The company will host a webcast and conference call and provide an investor presentation, offering detailed financial performance insights.

Sysco to Announce Third Quarter Fiscal Year 2026 Financial Results on April 28
SYY
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Sysco operates 337 distribution centers across 10 countries, serving approximately 730,000 customer locations.
  • Fiscal year 2025 sales exceeded $81 billion, reinforcing Sysco's position as the largest food-away-from-home distributor.
  • The company provides customized supply chain solutions and specialty products, supporting customers in various sectors including restaurants, healthcare, education, and lodging.

HOUSTON, April 07, 2026 (GLOBE NEWSWIRE) -- Sysco Corporation (NYSE:SYY) will host a conference call and webcast to discuss its third quarter fiscal year 2026 financial results at 10 a.m. ET on Tuesday, April 28, 2026.

All interested parties are invited to listen online at investors.sysco.com. Prior to the conference call and webcast, the company will also issue a news release and post a slide presentation in the investor relations section of its website. A replay of the webcast will be available online shortly after the live webcast is completed.

For purposes of public disclosure, including this and future similar events, Sysco uses the investor relations section of its website, found at investors.sysco.com, as the primary channel for publishing key information to its investors, some of which may contain material and previously non-public information.

About Sysco

Sysco is the global leader in selling, marketing and distributing food and related products to customers who prepare meals away from home. This includes restaurants, healthcare and educational facilities, lodging establishments, entertainment venues, and more. Sysco operates 337 distribution centers, in 10 countries, with 75,000 colleagues serving approximately 730,000 customer locations. The company generated sales of more than $81 billion in fiscal year 2025 that ended June 28, 2025.

As the world’s largest food-away-from-home distributor, Sysco offers customized supply chain solutions, bespoke specialty product offerings, and culinary support to drive customers to innovate and optimize their operations. We act as a trusted business partner to our customers, helping them grow through our industry-leading portfolio that includes fresh produce, premium proteins, specialty products, sustainably focused items, equipment and supplies, and innovative culinary solutions.

For more information, visit www.sysco.com. For important news and key information for Sysco investors, visit the Investor Relations section of the company’s website at investors.sysco.com.

For more information contact:
  Kevin KimCassandra MauelInvestor ContactMedia [email protected]@sysco.comT 281-584-1219T 281-584-1390


SYY-INVESTORS


Risks

  • The food service industry is sensitive to economic cycles, which can affect Sysco's sales performance.
  • Supply chain disruptions or cost fluctuations in food products, equipment, and supplies may impact profitability.
  • Customer demand variability in sectors like hospitality and entertainment could introduce revenue uncertainty.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026